Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis

Experimental and Molecular Pathology

Volumn 87, Issue 2, 2009, Pages 99-104

  Saouaf, Sandra J ^a   Li, Bin ^a   Zhang, Geng ^a   Shen, Yuan ^a   Furuuchi, Narumi ^a   Hancock, Wayne W ^a,b   Greene, Mark I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Autoimmunity; Rheumatoid arthritis; Suppression; T cell

Indexed keywords

CD4 ANTIGEN; COLLAGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOMODULATION; IMMUNOPATHOLOGY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MALE; MORBIDITY; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; ENZYME INHIBITORS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HISTONE DEACETYLASES; MALE; MICE; MICE, INBRED DBA; T-LYMPHOCYTES, REGULATORY; VALPROIC ACID;

EID: 70349385423     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.06.003     Document Type: Article

References (32)

1. Buglio D., Georgakis G.V., Hanabuchi S., Arima K., Khaskhely N.M., Liu Y.J., and Younes A. Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. Blood 112 (2008) 1424-1433
2. Camelo S., Iglesias A.H., Hwang D., Due B., Ryu H., Smith K., Gray S.G., Imitola J., Duran G., Assaf B., Langley B., Khoury S.J., Stephanopoulos G., De Girolami U., Ratan R.R., Ferrante R.J., and Dangond F. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 164 (2005) 10-21
3. Chung Y.L., Lee M.Y., Wang A.J., and Yao L.F. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol. Ther. 8 (2003) 707-717
4. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., and Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200 (2004) 277-285
5. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
6. Frey O., Petrow P.K., Gajda M., Siegmund K., Huehn J., Scheffold A., Hamann A., Radbruch A., and Brauer R. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res. Ther. 7 (2005) R291-301
7. Garcia B.A., Busby S.A., Shabanowitz J., Hunt D.F., and Mishra N. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. J. Proteome Res. 4 (2005) 2032-2042
8. Garcia-Morales I., Sancho Rieger J., Gil-Nagel A., and Herranz Fernandez J.L. Antiepileptic drugs: from scientific evidence to clinical practice. Neurologist 13 (2007) S20-28
9. Gray S.G., and Dangond F. Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis. Epigenetics 1 (2006) 67-75
10. Gu W., and Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90 (1997) 595-606
11. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
12. Joe B., Griffiths M.M., Remmers E.F., and Wilder R.L. Animal models of rheumatoid arthritis and related inflammation. Curr. Rheumatol. Rep. 1 (1999) 139-148
13. Jones J., Juengel E., Mickuckyte A., Hudak L., Wedel S., Jonas D., and Blaheta R.A. The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo. J. Cell. Mol. Med. 22 (2008) 293-299
14. Kannan K., Ortmann R.A., and Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 12 (2005) 167-181
15. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 (2003) 337-342
16. Kim W.U., Lee W.K., Ryoo J.W., Kim S.H., Kim J., Youn J., Min S.Y., Bae E.Y., Hwang S.Y., Park S.H., Cho C.S., Park J.S., and Kim H.Y. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. Arthritis Rheum. 46 (2002) 1109-1120
17. Li B., Samanta A., Song X., Furuuchi K., Iacono K.T., Kennedy S., Katsumata M., Saouaf S.J., and Greene M.I. FOXP3 ensembles in T-cell regulation. Immunol. Rev. 212 (2006) 99-113
18. Li B., Samanta A., Song X., Iacono K.T., Bembas K., Tao R., Basu S., Riley J.L., Hancock W.W., Shen Y., Saouaf S.J., and Greene M.I. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4571-4576
19. Lin H.S., Hu C.Y., Chan H.Y., Liew Y.Y., Huang H.P., Lepescheux L., Bastianelli E., Baron R., Rawadi G., and Clement-Lacroix P. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br. J. Pharmacol. 150 (2007) 862-872
20. Mishra N., Brown D.R., Olorenshaw I.M., and Kammer G.M. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2628-2633
21. Morgan M.E., Sutmuller R.P., Witteveen H.J., van Duivenvoorde L.M., Zanelli E., Melief C.J., Snijders A., Offringa R., de Vries R.R., and Toes R.E. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48 (2003) 1452-1460
22. Morgan M.E., Flierman R., van Duivenvoorde L.M., Witteveen H.J., van Ewijk W., van Laar J.M., de Vries R.R., and Toes R.E. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52 (2005) 2212-2221
23. Murali R., Cheng X., Berezov A., Du X., Schon A., Freire E., Xu X., Chen Y.H., and Greene M.I. Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10970-10975
24. Nag A., Germaniuk-Kurowska A., Dimri M., Sassack M.A., Gurumurthy C.B., Gao Q., Dimri G., Band H., and Band V. An essential role of human Ada3 in p53 acetylation. J. Biol. Chem. 282 (2007) 8812-8820
25. Nakamura C., Matsushita I., Kosaka E., Kondo T., and Kimura T. Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells. Rheumatology (Oxford) 47 (2008) 418-424
26. Nishida K., Komiyama T., Miyazawa S., Shen Z.N., Furumatsu T., Doi H., Yoshida A., Yamana J., Yamamura M., Ninomiya Y., Inoue H., and Asahara H. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression. Arthritis Rheum. 50 (2004) 3365-3376
27. Reilly C.M., Mishra N., Miller J.M., Joshi D., Ruiz P., Richon V.M., Marks P.A., and Gilkeson G.S. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J. Immunol. 173 (2004) 4171-4178
28. Reilly C.M., Thomas M., Gogal Jr. R., Olgun S., Santo A., Sodhi R., Samy E.T., Peng S.L., Gilkeson G.S., and Mishra N. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. J. Autoimmun. 31 (2008) 123-130
29. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?. Cell Mol. Life Sci. 64 (2007) 2090-2103
30. Samanta A., Li B., Song X., Bembas K., Zhang G., Katsumata M., Saouaf S.J., Wang Q., Hancock W.W., Shen Y., and Greene M.I. TGF-{beta} and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 14023-14027
31. Tao R., de Zoeten E.F., Ozkaynak E., Chen C., Wang L., Porrett P.M., Li B., Turka L.A., Olson E.N., Greene M.I., Wells A.D., and Hancock W.W. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13 (2007) 1299-1307
32. Valencia X., Stephens G., Goldbach-Mansky R., Wilson M., Shevach E.M., and Lipsky P.E. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108 (2006) 253-261